Omnitrope®
ACTIVE PRINCIPLE:
Somatotropin
INDICATION:
Dwarfism
Prader-Willi syndrome
Turner syndrome
DATE:
12/04/2006
STATUS:
Authorized
ACTIVE PRINCIPLE:
Somatotropin
INDICATION:
Dwarfism
Prader-Willi syndrome
Turner syndrome
DATE:
12/04/2006
STATUS:
Authorized